HSPA4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.197800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.933050E-01
Normal-vs-Stage2
6.129000E-01
Normal-vs-Stage3
3.666400E-01
Normal-vs-Stage4
1.172000E-01
Stage1-vs-Stage2
5.746000E-01
Stage1-vs-Stage3
4.758100E-02
Stage1-vs-Stage4
1.454980E-01
Stage2-vs-Stage3
7.702400E-02
Stage2-vs-Stage4
1.631170E-01
Stage3-vs-Stage4
4.508400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.330600E-01
Normal-vs-AfricanAmerican
6.334200E-01
Normal-vs-Asian
6.308400E-01
Caucasian-vs-AfricanAmerican
9.364000E-01
Caucasian-vs-Asian
6.765400E-01
AfricanAmerican-vs-Asian
8.784000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.213800E-01
Normal-vs-Female
6.149400E-01
Male-vs-Female
8.599000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.988600E-01
Normal-vs-Age(41-60Yrs)
3.282600E-01
Normal-vs-Age(61-80Yrs)
8.091000E-01
Normal-vs-Age(81-100Yrs)
6.116800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.458800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.911200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.115400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.480000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.758600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.133800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.574600E-01
Normal-vs-Daily Drinker
9.226000E-01
Normal-vs-Weekly Drinker
6.863400E-01
Normal-vs-Occasional Drinker
3.149200E-01
Normal-vs-Social Drinker
2.459600E-01
Non Drinker-vs-Daily Drinker
5.593400E-01
Non Drinker-vs-Weekly Drinker
6.966800E-01
Non Drinker-vs-Occasional Drinker
1.730440E-01
Non Drinker-vs-Social Drinker
2.281400E-01
Daily Drinker-vs-Weekly Drinker
3.629000E-01
Daily Drinker-vs-Occasional Drinker
4.828200E-02
Daily Drinker-vs-Social Drinker
6.120500E-02
Weekly Drinker-vs-Occasional Drinker
4.038800E-01
Weekly Drinker-vs-Social Drinker
4.581800E-01
Occasional Drinker-vs-Social Drinker
8.782200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.786190E-01
Normal-vs-Grade 2
1.626270E-02
Normal-vs-Grade 3
1.081670E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.992820E-01
Grade 1-vs-Grade 3
7.973800E-02
Grade 1-vs-Grade 4
1.786190E-01
Grade 2-vs-Grade 3
3.580000E-01
Grade 2-vs-Grade 4
1.626270E-02
Grade 3-vs-Grade 4
1.081670E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.802400E-01
Normal-vs-NonDiabetic
6.838400E-01
Diabetic-vs-NonDiabetic
9.909000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.582200E-01
Normal-vs-NoPancreatitis
6.625000E-01
Pancreatitis-vs-NoPancreatitis
4.512400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.908000E-01
Normal-vs-N1
6.320400E-01
N0-vs-N1
7.732200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.407200E-01
Normal-vs-TP53-NonMutant
7.080200E-01
TP53-Mutant-vs-TP53-NonMutant
8.044100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
